FDA Clears a New Artificial Pancreas System
The FDA cleared the iLet Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1…
Breakthrough T1D Staff Share Personal Stories About Diabetic Eye Disease
Breakthrough T1D staff share their experiences with diabetic eye disease to help raise awareness of the importance of being proactive…
FDA Approves Medtronic 780G Artificial Pancreas System
FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.
Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research
Aspect and Novo Nordisk announce a partnership, using Aspect’s bioprinting technology and Novo Nordisk’s expertise, to develop treatments for diabetes.
A Bittersweet Goodbye for Breakthrough T1D Champion Cynthia Rice
JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough…
Clinical Trials: The Ultimate Form of T1D Advocacy
Meet two type 1 diabetes (T1D) clinical trial participants who are helping improve lives and getting us closer to cures,…
Cell therapy moves forward across the pipeline
Beta cell replacement therapies aim to overcome the obstacles to realize their potential, but several approaches are making them a…
Who is at risk for type 1 diabetes?
Although its exact causes are unknown, researchers have uncovered type 1 diabetes (T1D) risk factors that increase a person's likelihood…
Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and Teens
The CLVer study found that newly diagnosed individuals on verapamil were making more insulin one year after diagnosis than those…
Is there a cure for type 1 diabetes?
There is currently no cure for type 1 diabetes (T1D), but Breakthrough T1D has a strategy to change this and…
